Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
In 1998 she moved on for an additional postdoctoral tenure at the Ludwig Institute for Cancer Research, Stockholm, in Dr. Per Ljungdahl’s lab. During this period she investigated a signal transduction pathway regulating the intracellular trafficking of plasma membrane proteins in eukaryotic cells. During the last four years at Ludwig she was in charge of starting a new research line aimed at the identification of novel drug targets for antifungal therapy. Her work showed that in Candida albicans, the sensor of extracellular amino acids not only regulates the expression of amino acid and oligopeptide permeases but also the secreted aspartyl proteases (SAPs). SAPs constitute one of the major virulence factors in fungal pathogens. For the first time, the transcription factor and the regulatory mechanisms underlying the expression of SAP2 were discovered.
In 2005, she started as a project leader at the Department of Developmental Biology at Stockholm University. Her research focused in the study of the non-homologous end joining pathway for the repair of double strand DNA breaks (DSB) using Kluyveromyces lactis as a model system. She demonstrated that intergenic regions and rDNA are more prone to encounter spontaneous mitotic DSBs as compared to coding regions.
In 2007 she was awarded a “Ramón y Cajal” contract and joined María Blasco’s group. Her mayor interest is to further study the interplay between DNA repair/check point mechanisms and telomere length and capping maintenance.